Abacus Global Management, Inc. - Q3 2025 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended September 30, 2025. Abacus Global Management, Inc. (Abacus) operates as a financial services company specializing in alternative asset management, life settlement solutions, and technology services. The company is classified as a smaller reporting company and an emerging growth company. During the period, Abacus completed several strategic acquisitions, including Carlisle Management, FCF Advisors, National Insurance Brokerage (NIB), and AccuQuote, significantly expanding its asset management and life solutions capabilities.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Total Revenue | $62,975,156 | $28,148,491 | $163,339,122 | $78,711,777 |
| Gross Profit | $55,319,458 | $25,960,510 | $142,520,373 | $71,059,365 |
| Operating Income | $22,413,178 | $6,849,971 | $65,959,737 | $15,873,870 |
| Net Income (Attributable to Abacus) | $7,075,348 | $(5,125,055) | $29,298,620 | $(5,703,817) |
| Diluted EPS | $0.07 | $(0.07) | $0.30 | $(0.09) |
| Cash and Equivalents | $86,418,953 | $131,944,282 (Dec 31, 2024) | $86,418,953 | $25,588,668 (Dec 31, 2023) |
| Total Debt (Principal) | $409,270,655 | $380,818,100 (Dec 31, 2024) | $409,270,655 | $380,818,100 (Dec 31, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 124% year-over-year for the quarter and 108% year-over-year for the nine-month period. This growth is primarily driven by the inclusion of Carlisle and FCF acquisitions (closed Dec 2024) and increased activity in the Life Solutions segment.
- Profitability Turnaround: The company returned to profitability, reporting net income of $7.1 million for Q3 2025 compared to a net loss of $5.1 million in Q3 2024. YTD 2025 net income was $29.3 million versus a loss of $5.7 million in YTD 2024.
- Life Solutions Performance: Life solutions revenue surged 93% in Q3 2025. The average realized gain on policies sold improved significantly to 36.6% in Q3 2025 from 19.0% in Q3 2024, reflecting strong institutional demand.
- Debt Structure: The company drew the full $50 million delayed draw term loan facility in September 2025, increasing total debt. However, it successfully extinguished market-indexed notes (LMATT) and redeemed all private placement warrants during the period.
- Stock Repurchases: The company utilized its stock repurchase program extensively, spending approximately $38.2 million on repurchases in the first nine months of 2025, exhausting the authorized amount under the prior plans.
Guidance, Outlook, and Risks
- Capital Deployment: Management highlighted an expanded capital base following a $90 million equity raise in late 2024 and a $100 million debt facility. This capital is being deployed to acquire a larger portfolio of life insurance policies.
- Subsequent Events:
- On October 22, 2025, the company successfully sold $50 million of securitized life insurance assets.
- On November 6, 2025, the Board authorized a new $10 million stock repurchase program and declared an annual cash dividend of $0.20 per share.
- Risks and Contingencies:
- Life Expectancy Accuracy: Returns are heavily dependent on the accuracy of life expectancy forecasts. Improvements in healthcare or longevity could delay death benefits and reduce returns.
- Valuation Sensitivity: The fair value of life settlement policies is sensitive to discount rates and historical realized gains. A 1% increase in the discount rate would decrease the fair value of the portfolio by approximately $7.7 million.
- Concentration: While no single customer exceeded 10% of revenue in 2025, the company relies on a limited number of external counterparties for policy sales.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the Senior Secured Credit Facility (SSCF) covenants, specifically the Secured Leverage Ratio and Asset Coverage Ratio, given the recent drawdown of the delayed draw facility.
- Life Settlement Valuation: Review the assumptions used in the Level 3 fair value measurements for life settlement policies, specifically the discount rate (currently 15%) and mortality tables, as these drive a significant portion of earnings.
- Related Party Transactions: Scrutinize the volume and pricing of life policy sales to related parties (Carlisle and LP Funds), which accounted for a substantial portion of Life Solutions revenue ($8.6 million in Q3 2025).
- Stock Repurchase Impact: Assess the impact of the exhausted $50 million repurchase authorization and the new $10 million program on future liquidity and share count.
- Intangible Amortization: Monitor the impact of amortization expenses from recent acquisitions (Carlisle, FCF, NIB, AccuQuote), which increased significantly to $14.3 million YTD 2025.